Bayer posts fourth quarter loss alongside strong sales in 2010
This article was originally published in Scrip
Executive Summary
German pharma giant Bayer posted an unexpected fourth quarter loss of €145 million, compared with a profit of €153 million in the same period of 2009, on the back of charges related to its Schering brand and costs of US legal proceedings.